Amy C. Peterson - 31 May 2021 Form 4 Insider Report for CytomX Therapeutics, Inc. (CTMX)

Role
EVP, Chief Development Officer
Signature
/s/ Lloyd Rowland, as Attorney-in-Fact for Amy C. Peterson
Issuer symbol
CTMX
Transactions as of
31 May 2021
Net transactions value
+$20,206
Form type
4
Filing time
08 Jun 2021, 13:07:11 UTC
Next filing
26 Oct 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTMX Common Stock Award $20,206 +3,320 +107% $6.09 6,421 31 May 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 3,320 shares were acquired pursuant to the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).